Lilly’s Triple-G Obesity Drug Clears First Late-Stage Diabetes TrialBusiness PenMarch 19, 2026April 22, 2026 March 19, 2026April 22, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”LLY” realtime=”true” api=”yahoo-finance”] Eli Lilly and Company (NYSE: LLY) has produced fresh data that could widen its lead in the race to...